Nancy Wisnewski
Net Worth

Last updated:

What is Nancy Wisnewski net worth?

The estimated net worth of Dr. Nancy Wisnewski is at least $8,703,104 as of 1 Sep 2022. He has earned $2,537,204 from insider trading and has received compensation worth at least $6,165,900 in Heska Corporation.

What is the salary of Nancy Wisnewski?

Dr. Nancy Wisnewski salary is $474,300 per year as Executive Vice President & Chief Operating Officer in Heska Corporation.

How old is Nancy Wisnewski?

Dr. Nancy Wisnewski is 62 years old, born in 1963.

What stocks does Nancy Wisnewski currently own?

As insider, Dr. Nancy Wisnewski owns shares in one company:

Company Title Shares Price per share Total value
Heska Corporation (HSKA) Executive Vice President & Chief Operating Officer 54,505 $0 $0

What does Heska Corporation do?

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.

HSKA logo
HSKA
Heska Corporation

Nancy Wisnewski insider trading

Heska Corporation

Dr. Nancy Wisnewski has made 19 insider trades between 2012-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 13,000 units of HSKA stock on 1 Dec 2015. As of 1 Sep 2022 he still owns at least 54,505 units of HSKA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 10,000 $8.55 $85,500
Option
Incentive Stock Option (right to buy) 10,000 $8.55 $85,500
Option
Common Stock 1,562 N/A N/A
Option
Performance Shares 1,562 N/A N/A
Option
Incentive Stock Option (right to buy) 10,000 $6.9 $69,000
Option
Common Stock 10,000 $6.9 $69,000
Sale
Common Stock 1,000 $270.43 $270,425
Sale
Common Stock 5,000 $197.85 $989,260
Sale
Common Stock 5,000 $197.85 $989,260
Option
Incentive Stock Option (right to buy) 7,500 $6.76 $50,700
Option
Common Stock 7,500 $6.76 $50,700
Option
Common Stock 1,563 N/A N/A
Option
Performance Shares 1,563 N/A N/A
Option
Incentive Stock Option (right to buy) 6,000 N/A N/A
Option
Common Stock 6,000 N/A N/A
Sale
Common Stock 500 N/A N/A
Sale
Common Stock 500 $140.42 $70,210
Sale
Common Stock 350 N/A N/A
Sale
Common Stock 150 N/A N/A
Sale
Common Stock 500 N/A N/A
Sale
Common Stock 1,000 N/A N/A
Sale
Common Stock 1,050 $103.83 $109,025
Sale
Common Stock 1,050 $103.83 $109,025
Sale
Common Stock 1,050 N/A N/A
Option
Common Stock 1,563 N/A N/A
Option
Performance Shares 1,563 N/A N/A
Option
Incentive Stock Option (right to buy) 6,000 N/A N/A
Option
Common Stock 7,000 N/A N/A
Option
Incentive Stock Option (right to buy) 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 750 N/A N/A
Sale
Common Stock 2,250 N/A N/A
Sale
Common Stock 1,200 N/A N/A
Sale
Common Stock 1,300 N/A N/A
Option
Common Stock 7,000 N/A N/A
Option
Incentive Stock Option (right to buy) 7,000 N/A N/A
Sale
Common Stock 825 N/A N/A
Sale
Common Stock 250 N/A N/A
Sale
Common Stock 500 N/A N/A
Option
Common Stock 6,000 N/A N/A
Option
Common Stock 6,000 $17.17 $103,020
Option
Incentive Stock Option (right to buy) 5,824 N/A N/A
Option
Common Stock 13,000 $12.5 $162,500
Option
Common Stock 13,000 N/A N/A
Option
Incentive Stock Option (right to buy) 1,671 N/A N/A
Option
Incentive Stock Option (right to buy) 6,500 $8.8 $57,200
Option
Common Stock 6,500 $8.8 $57,200
Option
Common Stock 1,500 $3.4 $5,100
Option
Incentive Stock Option (right to buy) 1,500 $3.4 $5,100

Heska key executives

Heska Corporation executives and other stock owners filed with the SEC:

  • Dr. Nancy Wisnewski (62) Executive Vice President & Chief Operating Officer
  • Mr. Kevin S. Wilson (53) Chief Executive Officer, Pres & Director
  • Mr. Steven M. Eyl (59) Executive Vice President, Chief Commercial Officer & Pres of scil animal care company
  • Ms. Catherine I. Grassman CPA (49) Executive Vice President & Chief Financial Officer